2.72
Scisparc Ltd (SPRC) 最新ニュース
SciSparc’s Patent Surge: Buy or Hold? - StocksToTrade
Why SciSparc Stock Is Gaining Today - Benzinga
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology - MSN
SciSparc Stocks Surge: A Strategic Leap Forward? - timothysykes.com
SciSparc stock soars after acquiring GERD treatment technology - Investing.com
SciSparc to acquire treasury of patents for medical endoscopy systems - TipRanks
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com India
SciSparc to acquire endoscopic system patents from Xylo Technologies By Investing.com - Investing.com South Africa
Scisparc shares climb 27.5% premarket; co says will buy a treasury of patents, trademarks and intellectual property rights from Xylo - MarketScreener
SciSparc Ltd. Signs Agreement to Acquire Patent and Intellectual Property Portfolio for Innovative MUSE™ Endoscopic System from Xylo Technologies Ltd. - Quiver Quantitative
SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity - Stock Titan
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - Stocktwits
SciSparc, Clearmind Medicine file Israeli patent application for depression - MSN
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will SciSparc Ltd. stock recover faster than peersGlobal Markets & Risk Managed Investment Signals - newser.com
How SciSparc Ltd. stock compares to industry benchmarksJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
SciSparc Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
SciSparc Announces New Patent Filing for Depression Treatment - TipRanks
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
[6-K] SciSparc Ltd. Current Report (Foreign Issuer) | SPRC SEC FilingForm 6-K - Stock Titan
SciSparc subsidiary files patent for depression treatment combination By Investing.com - Investing.com Australia
SciSparc subsidiary files patent for depression treatment combination - Investing.com
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - The Manila Times
SciSparc Ltd. Partner NeuroThera Labs Advances Depression Treatment with New Patent Application for Combination Therapy - Quiver Quantitative
SciSparc (Nasdaq: SPRC) Supports NeuroThera Israeli Patent for MEAI-PEA Depression Therapy - Stock Titan
Will SciSparc Ltd. stock gain from lower inflationWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com
Is SciSparc Ltd. stock entering bullish territoryJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Is SciSparc Ltd. stock in correction or buying zone2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Is SciSparc Ltd. stock a top momentum playMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
SciSparc Ltd. Releases Interim Financial Results for H1 2025 - MSN
How SciSparc Ltd. stock performs in interest rate cyclesJuly 2025 Earnings & Verified Momentum Watchlists - newser.com
What analysts say about SciSparc Ltd stockLong-Term Growth Stocks & Discover Stocks Experts Are Watching - earlytimes.in
Will SciSparc Ltd. bounce back from current supportJuly 2025 Setups & Fast Entry High Yield Tips - newser.com
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Scisparc Ltd. Net Worth (2025) - GuruFocus
大文字化:
|
ボリューム (24 時間):